A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...

Researchers at Kyoto University have discovered that an immune molecule found only in primates, called IGFL2, plays a key ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

Medically reviewed by Scott J. Zashin, MD Rheumatoid arthritis and lupus (systemic lupus erythematosus) are both autoimmune conditions that can cause fatigue, pain and swelling in your joints, and ...

Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside other inflammatory conditions.

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

Rheumatoid arthritis (RA) impacts thousands of Australians each year, causing pain, stiffness, and a steady decline in ...

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...